-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Objective: Families with multiple childhood systemic lupus erythematosus (SLE) episodes may have a strong genetic predisposition
METHODS: Sanger sequencing validated two ultra-rare predicted pathogenic risk variants identified by WES and additional variants in 562 additional SLE patients
RESULTS: These two familial ultra-rare, predicted loss-of-function (LOF) SAT1 variants exhibited X-linked recessive Mendelian inheritance in two unrelated African American families
Conclusions: This study identifies two novel SAT1 loss-of-function (LOF) variants, shows the ability of frameshift mutations to confer lupus, highlights the pathogenic role of dysregulated polyamine catabolism, and identifies SAT1 LOF variants for a new monogenic cause of SLE
Source: Xu L, Zhao J, Sun Q, Xu X, Wang L, Liu T, Wu Y, Zhu J, Geng L, Deng Y, Awgulewitsch A, Kamen DL, Oates JC, Raj P, Wakeland EK, Scofield RH, Guthridge JM, James JA, Hahn BH, McCurdy DK, Wang F, Zhang M, Tan W, Gilkeson GS, Tsao BP.